Post by
donmayne on Oct 06, 2021 5:34pm
RBC Capital analyst change
On August 3, RBC Capital reiterated their 1-year target of $US 13 (or $Cdn 16.37 approx). That was issued by Anton Hie.
Since then, Anton Hie has joined AdaptHealth as their VP of Finance.
https://www.linkedin.com/in/anton-hie-8544425/
It is a small world because AdaptHealth is in a similar space and, I hear, was at one time viewed as a potential suitor for VMD. AdaptHealth suffered major reputational loss when their former CEO was charged in Europe for tax issues. He resigned. I don't follow AdaptHealth but I heard that they had turnover of executive staff. Their revenue guidance for 2021 is $2.5 billion and their adjusted EBITA is $580 million. Perhaps Anton Hie has his sights set on VMD as a buyout possibility at his projected price plus or minus a premium. With 65% held by institutions, a buyout is possible given the cash on hand and failure of their IR efforts.
RBC Capital now lists Frank Morgan as the analyst for VMD at the same $US 13 price.
https://www.linkedin.com/in/frank-g-morgan-cfa-5895a87a/
Frank has an excellent reputation as an experienced analyst in the Healthcare Sector. In any event, I expect that he might revisit any inherited ratings from Anton Hie and perhaps reduce the rating so that it preserves his reputation. On the other hand, he may reasonably predict a near-term buyout and may want to take credit by continuing to recommend this target price.
Q3 revenue and earnings are a bit of an unknown. VMD was predicting a gradual return to normal in patient referrals. With the staff hirings, there will be some drag on the bottom line because not all staff will be performing at 100%.
Comment by
JackLambert on Oct 07, 2021 7:24am
Because stock buy back means "we can't do our jobs". Banks are often good at buybacks. I'm starting to wonder if we are all talking about the same company?
Comment by
lscfa on Oct 07, 2021 7:29am
I think they are sitting on the cash in the event a large contract is signed. $30 million buys only 6,000 ventilators.
Comment by
Tropicalsun on Oct 07, 2021 10:36am
Iscfa even if your theory was correct, with the Phillips recall, and covid, where would Viemed get 6,000 ventilators? How long would it take to fill an order that size?
Comment by
Tropicalsun on Oct 07, 2021 11:06am
Iscfa, on a side note did you ever get a response back from the company in regards to the remaining 95% untapped market?? I will assume because you didn't post anything, the answer is no.
Comment by
lscfa on Oct 07, 2021 6:11pm
Never got a reply but at least the SOBs know what investors are thinking. Re: ventilator supply, Rotech mentioned in its filings that is sourcing a new vent from China with FDA approval. Also Ventec's multi-functional vent has just been approved for single use reimbursement. https://stockhouse.com/companies/bullboard/t.vmd/viemed-healthcare-inc?postid=33907965
Comment by
lscfa on Oct 07, 2021 6:24pm
30,000 Ventec V+Pro ventilators in US govt. stockpiles. Time for govt to sell some back to industry to meet current shortfall. https://www.venteclife.com/news/general-motors-and-ventec-life-systems-joint-statement
Comment by
lscfa on Oct 08, 2021 11:29am
Look beyond the VA. e.g. The deal announced in Feb with Commonwealth Primary Care ACO, LLC which has 10,000 patients.
Comment by
Tropicalsun on Oct 08, 2021 11:51am
Good point Iscfa, I completely forgot about that, however the market is obviously saying Ho Hummm.
Comment by
besttobe on Oct 07, 2021 8:06am
Jomen....unless there is some extraordinary surprise, like a take over offer, I believe the S/P will remain flat in current range over the next year. As Hoyt said, they want to conserve cash, because of current industry headwinds I previously mentioned. IMO GLTA
Comment by
Tropicalsun on Oct 08, 2021 10:01am
Jackie, with all due respect, Viemed being bought out is pure speculation at this point in time. The stock ran to $16 when they announced inclusion on the russell 3000 index, not because of covid.
Comment by
JackLambert on Oct 08, 2021 1:35pm
Just messing with ya. nothing here makes any sense at all.